5-FU or GEM were able to synergistically enhance antibody dependent cell-mediated cytotoxic (ADCC) mediated killing of colon cancer cell lines by cetuximab (a monoclonal antibody targeting epidermal growth receptor, EGFR) by increasing expression of EGFR on tumors [67]. Here, EGFR is linked to colonic neoplasm.